Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.79 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.79 |
| ▸ | SLC22A8 | Q8TCC7 | 2/20 | 0.79 |
| ▸ | SLC22A11 | Q9NSA0 | 2/20 | 0.79 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.79 |
| ▸ | MAPT | P10636 | 9/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 9/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.67 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.67 |
| ▸ | BLM | P54132 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 10/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | PDE4A | P27815 | 1/20 | 0.56 |
| ▸ | KDR | P35968 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ceftezole SCHEMBL11033793 | 1.00 | LMNA (0.79) | LMNASLC22A6SLC22A8SLC22A11PTGS2 | |
| Ceftezole SCHEMBL11033790 | 1.00 | LMNA (0.79) | LMNASLC22A6SLC22A8SLC22A11PTGS2 | |
| Ceftezole SCHEMBL2259026 | 0.99 | LMNA (0.78) | LMNASLC22A6SLC22A8SLC22A11PTGS2 | |
| Ceftezole SCHEMBL1649887 | 0.92 | TDP1 (0.79) | LMNASLC22A6SLC22A8SLC22A11PTGS2 | |
| Cefazolin SCHEMBL3424683 | 0.88 | LMNA (1.00) | LMNASLC22A6SLC22A8SLC22A11PTGS2 | |
| Cefazolin SCHEMBL16072809 | 0.88 | LMNA (1.00) | LMNASLC22A6SLC22A8SLC22A11PTGS2 | |
| Cefazolin SCHEMBL11031717 | 0.88 | LMNA (1.00) | LMNASLC22A6SLC22A8SLC22A11PTGS2 | |
| Cefazolin SCHEMBL3894722 | 0.88 | LMNA (1.00) | LMNASLC22A6SLC22A8SLC22A11PTGS2 | |
| Cefazolin SCHEMBL2842 | 0.88 | LMNA (1.00) | LMNASLC22A6SLC22A8SLC22A11PTGS2 | |
| Cefazolin SCHEMBL4930576 | 0.88 | LMNA (1.00) | LMNASLC22A6SLC22A8SLC22A11PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4659 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637481-B2 | Boronic acid derivatives and therapeutic uses thereof | QPEX BIOPHARMA, INC. (US) | 2026-05-26 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| US-12371429-B2 | Antibiotic resistance-modifying tricyclic heteroaryl compounds and uses thereof | RECREO PHARMACEUTICALS LLC (US) | 2025-07-29 | — | — | US | claimed |
| US-20250222118-A1 | Beta-Lactam-Cannabinoid Conjugate Molecules | DIVERSE BIOTECH INC (US) | 2025-07-10 | — | — | US | claimed |
| CN-119838022-A | Amatoxin conjugates containing branched linkers | 杭州多禧生物科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| EP-0786999-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-08-06 | — | — | EP | claimed |
| US-5637579-A | BETA-LACTAMASE INHIBITORS; BACTERICIDES | HOFFMANN-LA ROCHE INC. (US) | 1997-06-10 | — | — | US | claimed |
| EP-0563387-B1 | CEPHALOSPORINASE TESTING AGENT | SHOWA PHARM CHEM IND (JP) | 1997-04-23 | — | — | EP | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| EP-0678095-A1 | CRYSTALLINE PENICILLIN DERIVATIVE, AND ITS PRODUCTION AND USE | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1995-10-25 | — | — | EP | claimed |
| WO-1995012601-A1 | CRYSTALLINE PENICILLIN DERIVATIVE, AND ITS PRODUCTION AND USE | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 1995-05-11 | — | — | WO | claimed |
| US-5350680-A | Determining if infection causing bacteria are beta-lactamase producers | SHOWA YAKUHIN KAKO CO., LTD. (JP) | 1994-09-27 | — | — | US | claimed |
| US-4414204-A | WITH A MURAMYL-PEPTIDE | CIBA-GEIGY CORPORATION (US) | 1983-11-08 | — | — | US | claimed |